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Objective. Identiﬁcation of the weight and postmenstrual age (PMA) at successful weaning of NCPAP in preterm neonates and
the factors inﬂuencing the successful wean. Study Design. Retrospective review of 454 neonates ≤32 weeks of gestational age (GA)
who were placed on NCPAP and successfully weaned to room air was performed. Results. Neonates had a mean birth weight (BW)
of 1357 ± 392 grams with a mean GA of 29.3 ± 2.2 weeks. Neonates were weaned oﬀ NCPAP at mean weight of 1611 ± 432
grams and mean PMA of 32.9 ± 2.4 weeks. Univariate analysis showed that chorioamnionitis, intubation, surfactant use, PDA,
sepsis/NEC, anemia, apnea, GER and IVH were signiﬁcantly associated with the time to NCPAP wean. On multivariate analysis,
among neonates that were intubated, BW was the only signiﬁcant factor (P<0.001) that was inversely related to time to successful
NCPAP wean. Amongst non-intubated neonates, along with BW (P<0.01), chorioamnionitis (P<0.01), anemia (P<0.0001),
and GER (P<0.02) played a signiﬁcant role in weaning from NCPAP. Conclusion. Neonates were weaned oﬀ NCPAP at mean
weight of 1611 ± 432 grams and mean PMA of 32.9 ± 2.4 weeks. BW signiﬁcantly aﬀects weaning among intubated and non-
intubated neonates, though in neonates who were never intubated chorioamnionitis, anemia and GER also signiﬁcantly aﬀected
the duration on NCPAP.
1.Introduction
Treatment of neonatal respiratory distress syndrome (RDS)
with intermittent positive pressure ventilation (IPPV) has
been associated with signiﬁcant pulmonary morbidity. Stud-
ies have shown that this morbidity can be reduced by use of
nasal continuous positive airway pressure (NCPAP) [1–4],
leading to increased use of NCPAP for the management of
RDS in preterm neonates in recent years. Multiple studies
have also demonstrated that NCPAP is a safe treatment
modality with no increase in short-term [5–10] and long-
term [11, 12] morbidities. It also has other beneﬁcial eﬀects
including induction of lung growth [13]. Although NCPAP
hasbeen usedmoreroutinely,thereispaucityofinformation
on factors aﬀecting the weaning process such as weight and
PMA at the time of successful weaning and the factors that
inﬂuence the weaning process [14, 15].
Recently, studies have been conducted to evaluate the
methods of NCPAP wean used at several neonatal intensive
care units (NICUs). These identiﬁed a lack of agreement
on the method of NCPAP wean used at various NICUs
with only 6% of the participating NICUs having written
guidelines regarding NCPAP wean. The start of the NCPAP
weaning was frequently arbitrarily determined by healthcare
providers (physicians, nurses, and respiratory technicians).
TherewasvariabilityinthemethodofweaningfromNCPAP,
which was attempted either by gradually increasing the time
of NCPAP, by reducing pressure, or by using both methods2 International Journal of Pediatrics
[16, 17]. Additionally, these surveys did not identify the age,
weight,orassociatedclinicalcomorbidities,whichmayaﬀect
successful weaning from NCPAP in preterm neonates. A
recent Cochrane review on weaning from NCPAP in preterm
neonates also highlighted the lack of information available
on the weaning from NCPAP [18].
Given this paucity of information, the objective of our
study was to identify the PMA and weight at which one
can successfully wean preterm neonates born ≤32 weeks of
gestational age oﬀ the NCPAP and the comorbidities that
may inﬂuence the success of NCPAP weaning.
2.MaterialsandMethods
2.1. Patients. A retrospective chart review was conducted on
all babies born at GA of ≤32 weeks who were admitted to
the NICU at Maimonides Infants and Children’s Hospital,
Brooklyn, between 1st of January 2003 and 31st of December
2007. This study was approved by the institutional review
board at Maimonides Medical Center and was conducted in
compliance with Health Insurance Portability and Account-
ability Act regulations.
There were 648 babies who were born at ≤32 weeks of
GA and admitted to the NICU during the study period. We
excluded all neonates who were stable in room air and did
not need any respiratory support (n = 103) and those who
died or transferred out while intubated or before they could
be weaned oﬀ NCPAP (n = 85). Those who were placed on
nasal cannula before meeting the criteria of successful wean-
ing from NCPAP (n = 6) were also excluded. Nasal SIMV
was not used in our nursery during the study period. Thus,
data from 454 eligible neonates was analyzed for the study.
The primary variables studied were BW, GA, ethnicity,
and gender. Additionally, weights and the PMA at the
following four time points were obtained: (1) when the
neonates were placed on NCPAP, (2) when they reached
FiO2 of 0.21 on NCPAP, (3) when weaning from NCPAP was
initiated, and (4) when the NCPAP was successfully weaned
oﬀ. The association of antenatal factors and postnatal co-
morbidities with the time to NCPAP weaning was also
studied. Antenatal factors such as use of antenatal steroids
(complete course) and magnesium sulphate, presence of
chorioamnionitis, preeclampsia (blood pressure of more
than 140/90 with proteinuria), and intrauterine growth
retardation (IUGR) (less than 3rd percentile on the growth
curve) were analyzed. Postnatal factors included in the
analysis were intubation prior to weaning from NCPAP, use
ofsurfactant,thepresenceofpatentductusarteriosus(PDA),
diagnosed in ﬁrst week (conﬁrmed by echocardiography),
anemia (hematocrit of <30 1 week prior to the initiation
of NCPAP weaning), GER (diagnosed clinically and treated
with H2 blocker or proton pump inhibitor), apnea (cessation
of respiration for >20 seconds associated with bradycardia or
cyanosis) >2i n1 2h o u r so r>3 in 24 hours with, at least, one
requiring bag and mask ventilation, and presence of intra-
ventricular hemorrhage (IVH) (diagnosed by ultrasound).
In addition, occurrence of sepsis/necrotizing enterocolitis
(NEC) (culture positive or radiologically proven) was also
included in the analysis. These two clinical conditions were
analyzed together as both similarly aﬀect the respiratory
system and hence the duration time on NCPAP through the
eﬀect of inﬂammatory mediators on the lungs. Caﬀeine was
exclusively used to treat neonates diagnosed with apnea.
2.2. Respiratory Management. Au n i f o r mm e t h o do fr e s -
piratory management has been practiced in our NICU
[19, 20] for over a decade. In summary, all spontaneously
breathing neonates with respiratory distress are placed on
bubble NCPAP using the Hudson RCI nasal prongs (Hudson
RespiratoryCare,Temecula,California,USA)with5cmH2O
pressure within ﬁrst 10 minutes of life irrespective of GA
and BW of the neonate. Neonates who are not breathing
spontaneously at birth or fail a trial of NCPAP are intubated.
Failure of NCPAP is deﬁned as increased work of breathing
determined clinically by persistent tachypnea (>60/minute
for >2 hours) and marked retractions, apnea as deﬁned
above, abnormal blood gases (2 arterial samples >2h o u r s
apart) low pH < 7.2, PaCO2 > 65mm of Hg, and PaO2= of
<50mm of Hg with FiO2 of ≥0.4. Surfactant is only used as
rescue treatment. The peak end expiratory pressure is kept at
5cmH 2O during the weaning process.
NCPAPweaningisinitiatedwhentheneonateisclinically
stable on room air NCPAP for 48 hours. When neonates are
weaned oﬀ NCPAP, special attention is paid to upper airway
suctioning and to keeping the neck in a neutral position to
prevent excessive ﬂexion or extension. Success of weaning
from NCPAP is deﬁned as the baby being stable in room air
without any respiratory support for 7 days.
2.3. Statistical Analysis. Statistical analysis was done using
STATA version 10 (StataCorp LP. College Station, Tex, USA).
Continuous variables such as BW, GA, PMA at various time
points of NCPAP weaning, and hematocrits were evaluated
for normality. While BW was normally distributed, GA was
not. As expected, those born at a younger GA were on
NCPAP for a longer duration. To accommodate to this, we
used PMA at complete weaning of NCPAP as the outcome
variable of interest, since this was normally distributed in
our sample. Univariate analysis was conducted using the t-
test or analysis of variance for continuous variables and chi-
squaretestforcategoricalvariablestoidentifytheassociation
of clinical variables with the PMA at NCPAP weaning. To
study the association of ethnicity with NCPAP weaning,
Caucasians were used as the reference group. The Spearman
correlation was used to study the association of NCPAP
weaning with continuous variables such as hematocrit levels.
Linear regression analysis was done to identify the
signiﬁcance of the association of the variables identiﬁed
by univariate analysis on the primary outcome variable of
interest, that is, the PMA at successful weaning from NCPAP
when adjusted for other clinical variables. Variables of epi-
demiological signiﬁcance such as gender were retained in the
model even though they did not reach statistical signiﬁcance
in univariate analysis. We identiﬁed a signiﬁcant interaction
between birth weight and intubation. To account for this,
a stratiﬁed analysis was performed, based on intubation
status, as shown in Table 4. In addition, there was signif-
icant collinearity between intubation and surfactant, PDA,International Journal of Pediatrics 3
Table 1: Demographic and clinical data of the study population.
Demographic/clinical
characteristic
Full cohort
n = 454
Nonintubated
n = 326
Intubated
n = 128 P value
n (%) n (%) n (%)
Male 242 (53.3) 179 (54.9) 63 (49.2) 0.29
Ethnicity
White 133 (29.3) 93 (28.5) 40 (31.3) 0.59
African Americans 79 (17.4) 58 (17.8) 21 (16.4)
Hispanics 108 (23.8) 83 (25.5) 25 (19.5)
Asians 88 (19.4) 63 (19.1) 26 (20.3)
Multiracial 46 (10.1) 30 (9.2) 16 (12.5)
Antenatal steroids 361(79.5) 257 (78.8) 104 (81.3) 0.56
Chorioamnionitis 21 (4.6) 14 (4.5) 7 (5.5) 0.58
Preeclampsia 72 (15.9) 54 (16.6) 18 (14.1) 0.50
Magnesium sulphate use 203 (44.7) 135 (41.1) 68 (53.1) 0.02
IUGR 19 (4.2) 13 (3.9) 6 (4.7) 0.74
Intubation 128 (28.3)
Surfactant 89 (19.6) 0 (0) 89 (69.5)
IVH 69 (15.1) 26 (8.0) 43 (33.6) <0.001
PDA 167 (36.9) 19 (5.8) 66 (51.6) <0.0001
Sepsis/NEC 40 (8.8) 20 (6.1) 20 (15.6) <0.001
Anemia 273 (80.1) 150 (46.0) 123 (96.0) <0.0001
Apnea 100 (22.3) 45 (13.8) 55 (42.9) <0.0001
GE reﬂux 29 (6.9) 7 (2.1) 22 (17.2) <0.001
BPD 50 7 (2.1) 43 (33.6) <0.001
Abbreviations: IUGR: intrauterine growth retardation, PDA: patent ductus arteriosus, IVH: intraventricular hemorhage, NEC: necrotizing enterocolitis,
GE reﬂux: gastroesophageal reﬂux.
and apnea. For this reason, these variables were not included
in the ﬁnal stratiﬁed model. Regression diagnostics were
performed to ensure that assumptions of linear regression
analysis were not violated.
3. Results
Fortheentirestudypopulation,themeanBWwas1357±392
grams and mean GA was 29.3 ± 2.2 weeks. Demographic
and clinical data of the study cohort as a whole and when
stratiﬁed by intubation is shown in Table 1. There was no
eﬀect of gender or of ethnicity on the PMA at successful
NCPAP weaning.
The weights and PMA of the neonates at various NCPAP
time points are shown in Table 2. The mean GA of those
requiring intubation was 27.3 ± 2.1 weeks and of those not
requiring intubation was 30.1 ± 1.7w e e k s( P<0.0001).
There were signiﬁcant diﬀerences between those who were
intubated and those who did not require intubation in the
PMA and their weights at various NCPAP time points.
As shown in Figures 1 and 2, there was a signiﬁcant
inverse correlation between GA (r =− 0.11, P<0.0001)
and BW (r =− 0.12, P<0.0001) to PMA at successful
NCPAP weaning. The beta for the regression line for GA was
−0.4; hence, the duration on NCPAP decreased by 0.4 weeks
for every week increase in GA. Similarly the beta for the
regression line for BW was −0.21; the duration of NCPAP
decreased by 0.2 weeks for every 100 grams increase in BW.
Univariate analysis of clinical comorbidities with PMA
at successful NCPAP weaning is shown in Table 3.T h e r e
was a signiﬁcant association of PMA at successful NCPAP
weaning with chorioamnionitis, intubation, and comorbidi-
ties such as PDA, sepsis/NEC, anemia, apnea, GER, and
IVH. There was signiﬁcant association between PDA, apnea,
and surfactant use and successful NCPAP weaning in our
study,butsincetherewascollinearitybetweenthesevariables
and intubation, we used intubation as a marker for these
variables in multivariate analysis. In addition to BW and GA,
successful weaning had a signiﬁcant inverse correlation with
hematocrit (r =− 0.44, P<0.001) and positive correlation
with the severity of IVH (r = 0.34, P<0.0001).
As shown in Table 4, in multivariate analysis, BW,
chorioamnionitis, anemia, GER, and IVH were independent
predictors for successful NCPAP weaning. In the stratiﬁed
model, among those neonates who were not intubated, BW,
chorioamnionitis, anemia, and GER remained independent
predictors of successful NCPAP weaning. On the other hand,
among those who were intubated prior to weaning, BW
was the only independent predictor of successful NCPAP
weaning with the other comorbid conditions not reaching
statistical signiﬁcance. In the whole cohort, length of stay
on NCPAP increased by 1.1 weeks in those who had4 International Journal of Pediatrics
Table 2: Weight (grams) and postmenstrual age (PMA in weeks) at various NCPAP time points, for the entire cohort and for subgroups
stratiﬁed by intubation.
Full cohort (n = 454) Nonintubated (n = 326) Intubation (n = 128)
Weight PMA Weight PMA Weight PMA
At start of NCPAP 1356 ±392 29.6 ±2.1 1480 ±346 30.3 ±1.7 1037 ±315∗ 27.9±2.1∗∗∗
Reaching 0.21 FiO2 NCPAP 1342 ±377 30.1 ±2.1 1441 ±344 30.5 ±1.7 1089 ±339∗ 29 ±2.6∗
Initiation of NCPAP weaning 1492 ±376 31.9 ±2.2 1462 ±345 31.3 ±1.4 1570 ±438∗ 33.2 ±2.9∗
Successful NCPAP weaning 1611 ±432 32.9 ±2.5 1580 ±381 32.1 ±1.7 1869 ±484∗∗ 35 ±2.9∗∗
∗P<0.01, ∗∗P<0.001, ∗∗∗P<0.0001 when the weights and PMA of intubated neonates were compared to those nonintubated.
25
30
35
40
45
P
o
s
t
m
e
n
s
t
r
u
a
l
 
a
g
e
 
a
t
 
s
u
c
c
e
s
s
f
u
l
N
C
P
A
P
 
w
e
a
n
i
n
g
22 24 26 28 30 32
Gestational age
Week ﬁnal
Fitted values
r =− 0.11, P<0.0001
Figure 1: Correlation between GA and PMA at successful NCPAP
weaning.
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Figure 2: Correlation between BW and PMA at successful NCPAP
weaning.
chorioamnionitis, 1 week in those who had anemia, and 1.9
weeks in those who had GER.
4. Discussion
We found that GA and BW were strongly correlated with
the duration of NCPAP in neonates born less than 32 weeks
of gestation but there was no association with ethnicity or
gender. These ﬁndings diﬀer from previous studies that have
demonstrated links between ethnicity and the severity of
RDS [21]. These diﬀerences in the observation may be due
to the relatively small sample size of our study as gender- and
ethnicity-speciﬁc diﬀerencein disease severity havebeenelu-
cidated in large-population-based epidemiological studies.
While several factors were found to be associated with
increased time on NCPAP, we identiﬁed that there was a
diﬀerence in their role among neonates that were intubated
and those who were not intubated. The time to successful
NCPAP weaning was longer among nonintubated preterm
neonates who had evidence of maternal chorioamnionitis,
anemia, and gastroesophageal reﬂux. However, among those
neonates who were intubated, weaning from NCPAP was not
associated with any of these factors.
In the nonintubated neonates, maternal chorioamnioni-
tis was associated with increased length of time on NCPAP,
which may be due to the injury caused by inﬂammatory
mediators to the immature lungs, predisposing them to
develop chronic lung disease [22–24]. The eﬀects of anemia
on the duration of NCPAP are likely due to decrease in
oxygen delivery and increase in cardiac load and work
of breathing. Studies have linked anemia with failure of
extubation in children and adults, but similar ﬁndings
have not been reported with weaning of NCPAP [25].
The eﬀect of GER on failure to wean oﬀ NCPAP could
be related to its association with increased incidence and
severity of apneas related to acid reﬂux and associated lung
inﬂammation related to frequent aspirations [26]. However,
prior studies have failed to demonstrate this association [27].
We also found preterm neonates with GER had a higher
incidence of BPD. This has been previously reported and
may further explain the association between GER and the
longerdurationofNCPAP use[28].W hilew eha v eid e ntiﬁed
these associations, further studies are needed to corroborate
these ﬁndings since they have direct clinical application and
signiﬁcance on management of preterm neonates. However,
the associations identiﬁed in our study highlight the need
for appropriate identiﬁcation and management of these
comorbid conditions to facilitate early weaning of NCPAP.
The delayed weaning from NCPAP in the intubated
preterm neonates not only may be related to the immaturity
of the lungs (as the intubated preterm neonates had lower
gestational age), but could also be due to the ventilator-
induced lung injury associated with intubation and positive-
pressure ventilation. The process of intubation not onlyInternational Journal of Pediatrics 5
Table 3: Eﬀect of clinical factors on PMA in weeks at successful NCPAP weaning.
Present∗ Absent∗ P-value
Antenatal steroids 32.9±2.5 32.7±2.2 P = 0.38
Chorioamnionitis 34.1±2.8 32.9±2.4 P<0.02
Preeclampsia 32.5±2.2 33±2.5 P = 0.14
Magnesium sulphate use 33.1±2.7 32.8±2.2 P = 0.26
IUGR 33.1±2.2 32.9± 2.5 P = 0.72
Intubation 35.0±2.9 32.1±1.7 P<0.00001
PDA 34.2±2.9 32.2±1.7 P<0.0001
Sepsis/NEC 34.2± 2.5 32.8±2.4 P<0.0001
Anemia 33.7±2.8 31.8±1.2 P<0.0001
Apnea 33.9±2.6 32.7±2.3 P<0.0001
GE reﬂux 35.6± 3.5 32.8±2.3 P<0.00001
IVH (grades3/4) 34.5±3.4 32.6±2.1 P<0.0001
∗PMA is reported as mean ±SD.
Abbreviations: IUGR: intrauterine growth retardation, PDA: patent ductus arteriosus, NEC: necrotizing enterocolitis, GE Reﬂux: gastroesophageal reﬂux,
IVH: intraventricular hemorhage.
Table 4: Multivariate analysis for PMA at successful NCPAP weaning and signiﬁcant predictor variables, analysis done for the group as a
whole and when stratiﬁed by intubation.
Full cohort (n = 454) Nonintubated (n = 326) Intubated (n = 128)
Beta 95% CI P value Beta 95% CI P value Beta 95% CI P value
BW −0.90 −1.50–0.28 0.004 −0.76 −0.17–1.30 0.01 −2.50 −4.02–0.99 0.001
Gender −0.14 −0.54–0.26 0.5 −0.15 −0.51–0.20 0.39 −0.13 −1.10–0.85 0.8
Chorioamnionitis 1.14 0.19–2.10 <0.01 0.72 0.16–1.60 0.01 0.95 −1.18–3.08 0.38
Sepsis/NEC 0.67 −0.05–1.38 0.06 0.71 −0.03–1.50 0.06 0.21 −1.12–1.54 0.75
Anemia 1.05 0.56–1.55 <.0001 0.91 0.50–1.30 <.001 0.61 −2.10–3.40 0.69
IVH 1.14 0.57–1.72 <.01 0.52 −0.13–1.18 0.1 0.80 −0.20–1.82 0.12
GE reﬂux 1.99 1.16–2.82 <.0001 1.44 0.23–2.65 .02 1.23 −0.06–2.52 0.06
Abbreviations: BW: birth weight, IVH: intraventricular hemmorhage, NEC: necrotizing enterocolitis, GE Reﬂux: gastroesophageal reﬂux.
increases the chances of hemodynamic instability [29]b u t
also bridges the unsterile upper airway to that of the lower
airway leading to increased incidence of colonization and
infection of the lower airways and lungs causing lung injury
[30]. Positive-pressure ventilation also causes trauma to the
lungs by multiple mechanisms such as barotrauma, volu-
trauma, atelectrauma, and biotrauma [31]. In multivariate
analysis, BW was the only signiﬁcant factor determining
time for weaning among those preterm neonates who were
intubated with no association identiﬁed with the comorbid
conditions that were found to be signiﬁcant in those who
were not intubated. It may be hypothesized that the role
of these comorbidities was masked by the immaturity of
the lungs and severity of ventilation-induced injury in the
intubated neonates. Furthermore, intubated neonates were
on NCPAP with FiO2 of 0.21 longer than their nonintubated
counterparts. As intubation and ventilation are associated
withpulmonaryinjuryandNCPAPhelpsinlunggrowthand
repair [13], intubated neonates took longer to reach a point
at which they could be weaned oﬀ NCPAP even when they
reached room air NCPAP. However this is the ﬁrst study to
identify diﬀerences in the association of clinical morbidities
with NCPAP weaning among neonates by intubation status.
Hence future studies are needed to corroborate our ﬁndings.
We recognize that caﬀeine use was limited to the preterm
neonates with signiﬁcant apnea. These neonates were on
NCPAP for a longer duration than those without apneas.
In keeping with the ﬁndings of Schmidt et.al. [32], if all
our preterm neonates had received caﬀeine, the diﬀerence
between the duration of NCPAP in the nonintubated
and the intubated neonates would have been expected to
more pronounced than that observed, as the nonintubated
neonates would be able to come oﬀ NCPAP even earlier.
There are certain limitations to this study, speciﬁcally,
those inherent to retrospective analysis and those related
to the information derived from a single center. One
feature which is unique to our unit is the lower incidence
of bronchopulmonary dysplasia (BPD), despite a similar
incidence of RDS, compared to other centers in the Vermont
Oxford database. The average incidence of BPD in less than
1500 gram preterm neonates in our NICU varied from 7.4%
to 10.5% as compared to the 26.7% to 29.7% in the database
during the 5-year study period. However, as NCPAP has
been associated with lower incidence of BPD rates [33], we6 International Journal of Pediatrics
attribute these diﬀerences to the higher use of NCPAP in our
NICU as compared to other centers. Further, the diagnosis
of GER was made clinically and not by pH probe, but if a pH
probe study was performed, more cases of subclinical GER
would be diagnosed likely making the association of weaning
failure and GER even stronger. Moreover, since anemia was
signiﬁcantly related to the success of NCPAP weaning, trans-
fusions may have impacted the success of weaning. However,
as the transfusion threshold was the same for all the neonates
priortotheweaningofNCPAP,irrespectiveoftheintubation
status, it was likely not associated with any misclassiﬁcation
bias. Additionally, we did not use nasal SIMV during NCPAP
weaning. We recognize that the judicious use of this tech-
nique might have reduced the need of ventilation and may
have decreased the time on NCPAP as suggested by a recent
review [34].Anotherlimitationinthisstudywastheinability
to determine which method of weaning (sudden removal
of NCPAP, gradual weaning by decreasing pressure or by
gradually increasing time oﬀ NCPAP) was better in getting
theneonatesweanedfromtheNCPAPearlierorifanyfactors
studied had diﬀerent relationship with the weaning tech-
niques. This was diﬃcult to evaluate due to the retrospective
natureofthestudy.Furtherstudiesareneededtoevaluatethe
best method to wean preterm neonates oﬀ NCPAP.
In conclusion, our ﬁndings suggest that in preterm
neonates, NCPAP can be successfully weaned oﬀ at a mean
PMA of 32.9 ± 2.4 weeks and weight of 1611 ± 432 grams.
There was an inverse relationship between time to success-
ful NCPAP weaning and BW. In addition, among those
neonates who were not intubated, prevention of maternal
chorioamnionitis, identiﬁcation and treatment of anemia
and GER may reduce the time on NCPAP. Our ﬁndings
provide neonatal health care providers clinical information
on successful NCPAP weaning that may be used to initiate
wean and help in decreasing the number of weaning failures.
This information could also be used to counsel parents on
the time when neonates could be expected to be successfully
weaned from NCPAP. As our ﬁndings are from a single
clinical center, future multicenter trials are needed to study
whether these factors uniformly inﬂuence NCPAP wean in
diﬀerent neonatal intensive care units.
Abbreviations
PMA: Postmenstrual age
GA: Gestational age
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NCPAP: Nasal continuous positive airway pressure
GER: Gastro-esophageal reﬂux
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NICU: Neonatal intensive care unit
IUGR: Intra-uterine growth retardation
PDA: Patent ductus arteriosus
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BPD: Broncho-pulmonary dysplasia.
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